Le Lézard
Classified in: Health, Science and technology
Subjects: SVY, TDS

JUUL Labs Presents Findings from Cytotoxicity Study at The Tobacco Science Research Conference


SAN FRANCISCO, Sept. 17, 2018 /PRNewswire/ -- JUUL Labs, Inc. today announced results from a preliminary study on the cytotoxicity of aerosol generated from JUUL's Menthol, Mint and Cucumber 5% nicotine-e-liquid filled pods. The findings, "Neutral Red Uptake (NRU) Cytotoxicity Analysis of Aerosol Generated from a Temperature-Regulated Nicotine-Salt Based Ends Product," were presented at a poster session at the 72nd Tobacco Science Research Conference in Memphis, TN.

In accordance with the Organisation for Economic Co-operation and Development (OECD) guidelines, an independent contract laboratory, Enthalpy Analytical, measured and compared the toxicity to living cells of aerosol generated from JUUL's Menthol, Mint and Cucumber 5% nicotine-e-liquid filled pods with that of tobacco cigarettes. The study demonstrated no significant aerosol toxicity at any of the observed concentrations for JUUL's Menthol, Mint and Cucumber pods compared to a cigarette control.

"We are encouraged by the results of this study, in which tested aerosols generated from JUUL were not cytotoxic to living cells," said Dr. Manoj Misra, study author and head of Toxicology at JUUL Labs. "These findings add to the growing body of evidence regarding use of JUUL as an alternative to combustible cigarettes, and we are committed to future rigorous, independent and peer-reviewed clinical trials and behavioral studies."

Authors of the study include Dr. Manoj Misra of JUUL Labs and Drs. I. Gene Gillman and Pooja Desai of Enthalpy Analytical.

About JUUL Labs

JUUL Labs is a technology company dedicated to eliminating cigarettes by offering existing adult smokers a true alternative to combustible cigarettes. The company's research shows that more than one million smokers have already switched to JUUL, and it is working to enable millions more to switch in the coming years through technological innovations.

Media Contact: Victoria Davis, JUUL Labs, [email protected]

SOURCE JUUL Labs, Inc.


These press releases may also interest you

at 12:05
VirtualHealth is excited to share that its HELIOS platform was named the winner of a Bronze Stevie® Award in the Healthcare Technology Solution category in The 22nd Annual American Business Awards® today. More than 3,700 nominations were submitted...

at 12:02
On May 1, 2024, Toronto Public Health (TPH) will host Diverse Dialogues: Stigma & Breaking Barriers. The event will bring together distinguished speakers to explore the challenging and thought-provoking topic about how negative labels and biases...

at 11:56
As the demand for cosmetic procedures continues to rise, patients are seeking more advanced and effective options for achieving a youthful and rejuvenated appearance. In response to this, Dr. Ronald Demeo has introduced the Next Level Deep Plane Face...

at 11:50
Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company") today reported its 2023 consolidated annual financial results, as of December 31, 2023, and provided financial information (unaudited)...

at 11:34
At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided: Resolution in accordance with the Board's proposed dividend of SEK 1.00 per share for the financial year 2023. 29 April, 2024 was adopted as the...

at 11:25
TimelyCare, higher education's most trusted virtual health and well-being provider, has earned recognition as one of the World's Best Digital Health Companies by Newsweek, and has been awarded five Top Workplaces Awards for culture excellence....



News published on and distributed by: